Organizer(s): Edward S. Boyden, Klaus M. Hahn and Chandra TuckerDate: March 12 - 16, 2015
Location: Westin Downtown Denver, Denver, CO, USA
The complexity of biological systems demands tools that enable temporally and spatially precise control of defined signaling pathways. Optogenetics is a new and rapidly evolving field that combines light control with genetic engineering, allowing conditional regulation of signaling processes with seconds and microns precision. Using optogenetic probes, the functions of specific molecules and pathways, the behaviors of individual cells, and the interactions of groups of cells in complex organisms can be precisely interrogated. This symposium seeks to bring together a broad range of researchers developing and using optogenetic probes with those developing related technologies. Specific goals include: 1) To present the latest innovative, genetically-encoded tools and technologies for manipulating biological systems with light; 2) To promote exchange between those developing light-responsive probes and developers of related tools (e.g., biosensors, hardware) that will maximize the power of optogenetics; and 3) To foster the exchange of ideas between optogenetic tool developers and users. This bi-directional feedback has occurred in the neurosciences but not more broadly across biology. No other meeting focuses on these three topics in quite this way. This meeting should facilitate the development and dissemination of a diversity of new optical tools, bring together a diverse but synergistic group of innovators and experimentalists, and ultimately open up new experimental avenues for study that will transform diverse fields.
Scholarship Deadline: November 12 2014
Discounted Abstract Deadline: November 12 2014
Abstract Deadline: December 11 2014
Discounted Registration Deadline: January 13 2015
We gratefully acknowledge additional support for this conference from:
Intelligent Imaging Innovations (3i)
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13NS090878-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.